• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

Innovate IndianaNews and information on how IU is driving innovation, entrepreneurship and economic development

McROBBIE: Indiana Biosciences Research Institute is positioned to drive a new wave of medical innovation and economic prosperity

Posted on March 15, 2016 by michael a. mcrobbie

Screen Shot 2016-03-15 at 11.59.26 AMThe decision by Lilly Endowment and the Eli Lilly and Co. Foundation, announced two weeks ago, to pledge a combined $100 million to further the development of the Indiana Biosciences Research Institute is the latest evidence of the extraordinary commitment by many of the state’s leading institutions to making Indiana a hotbed of research aimed at addressing some of the nation’s most pressing medical challenges.

This most welcome news comes less than a month after IBRI announced it had appointed Raghu Mirmira, one the IU School of Medicine’s top faculty members and one of the country’s leading metabolic disease researchers, as the institute’s first Indiana Research Fellow and interim scientific director, in addition to his posts at the IU School of Medicine.

Indeed, IBRI — formed in 2013 by leading Indiana-based life sciences companies, healthcare providers and academic partners, and with key Indiana state government financial support — has gained considerable momentum in recent months.

In addition to the most recent announcements, the institute — the first of its kind in the nation — is poised to be the anchor tenant in the 16 Tech innovation community being conceived just north of Eskenazi Hospital and has been launched in research space in the 16 Tech area provided by the IU School of Medicine.

Already, companies such as Eli Lilly, Roche Diagnostics, Dow AgroSciences and Cook Medical Group have established Indiana as a credible player in the exploding life sciences arena. Additionally, Indiana is fortunate to be home to some of the very best research universities in the nation, as well as the country’s largest medical school and a top-flight hospital system in IU Health.

Still, with the stakes so high – both in terms of the health of our citizens and the potential economic impact associated with a thriving biosciences industry – it’s incumbent that state government, businesses, healthcare providers and universities work collaboratively to create a culture of “discovery with purpose” that attracts the best scientific minds in the country.

Michael A. McRobbieIndiana is fortunate to be home to some of the very best research universities in the nation, as well as the country’s largest medical school and a top-flight hospital system in IU Health. Still, with the stakes so high – both in terms of the health of our citizens and the potential economic impact associated with a thriving biosciences industry – it’s incumbent that state government, businesses, healthcare providers and universities work collaboratively to create a culture of “discovery with purpose” that attracts the best scientific minds in the country.

— IU President Michael A. McRobbie

IBRI, with its unique organizational structure and focus on discoveries leading to innovations for people suffering from metabolic disease and poor nutrition, holds the promise to be the vehicle that drives growth in these vitally important areas. At the same time, a burgeoning biosciences community has the potential to bring hundreds of scientists and dozens of health-related firms to Indiana, ultimately generating billions of dollars in economic activity each year.

I’m proud to say that Indiana University has been an active partner in the IBRI since its inception.

For example, IBRI’s focus on diabetes and metabolic diseases dovetails with one the IU School of Medicine’s scientific research priorities. We also expect the IU Center for Diabetes and Metabolic Diseases to become a valued research partner to IBRI and anticipate that many of IBRI’s researchers will hold faculty positions in the school. Additionally, the IBRI should provide valuable internship and research opportunities for IU students.

Central to the long-term success of medical research is a robust platform to translate scientific breakthroughs into viable patient treatments, which is precisely the mission of the Indiana Clinical and Translational Services Institute.

CTSI, a consortium of IU, Purdue and Notre Dame, has established itself as one of the premier institutions of its type, despite being formed just eight years ago. Through its membership in CTSI, the IBRI, in concert with its industry partners, will be able to create a novel and powerful approach to help fulfill its mission.

To be sure, much work needs to be done to create the critical mass for IBRI to permanently take root as an integral part of the state’s life sciences economy. With each passing month, however, the pieces are falling into place for Indiana to be a national leader in biosciences research, and in the development of life-changing patient treatments.

This is one investment that stands to benefit each and every Hoosier for generations to come and one in which Indiana University is committed to playing a leadership role.

This opinion-editorial column also appeared in the March 12 edition of the Indianapolis Business Journal.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Filed under: Economic DevelopmentTagged Economic Outlook/Forecast, Eli Lilly & Co. Foundation, Eskenazi Hospital, Funding Opportunities for Research Commercialization and Economic Success, Indiana Biosciences Research Institute, Indiana Biosciences Research Institute, Indiana Clinical and Translational Sciences Institute, Intellectual property, IU Health, IU School of Medicine, Life Sciences, Lilly Endowment, Michael A. McRobbie, Office of the Vice President for Engagement, Office of the Vice President for Research, Purdue University, STEM (science, Technology Transfer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Innovate Indiana Button

Search Innovate Indiana

About Innovate Indiana

Join us as we highlight how IU innovation is accelerating economic growth in Indiana and beyond and creating a culture of entrepreneurship across the Hoosier state.

Innovate Indiana is maintained by the Indiana University Office of the Vice President for University Relations.

Subscribe to the Innovate Indiana Blog

Sign up to receive regular updates from Innovate Indiana Blog

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent Posts

  • IU researchers seek to commercialize AI tool to identify undiagnosed cases of early-stage Alzheimer’s disease and related dementia January 24, 2023
  • IU researchers win Translational Research grant for plastic neutron shield material technology January 20, 2023
  • IU program hits new milestones on path to accelerate new innovations in defense, national security November 18, 2022
  • In the trenches: IUPUI students put data skills to the test in helping to determine economic impact of College Football Playoff title game November 17, 2022
  • Shining the spotlight on IU entrepreneurs, innovators November 15, 2022

Categories

Bookmarks

  • Innovate Indiana website
  • IU Center on Representative Government
  • IU Impact
  • IU Innovation and Commercialization Office
  • IU Office of the Vice President for Research
  • IU Office of the Vice President for University Relations
  • IU Ventures

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.